NCT07661355 Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers
| NCT ID | NCT07661355 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Care Transition |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,560 participants |
| Start Date | 2026-07-22 |
| Primary Completion | 2031-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,560 participants in total. It began in 2026-07-22 with a primary completion date of 2031-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates better ways to help people after they leave the hospital and how to involve their families in this process. The main goal is to see if adding family support to a patient-centered hospital-to-home intervention helps patients stay safely at home, spend fewer days back in the emergency room or going back into the hospital. The study team also wants to see if the family-centered approach helps improve the patient's ability to do everyday activities without feeling overwhelmed. Two approaches are being compared: one focuses just on the patient, and the other includes special strategies to better support families involved too. Family will be involved in assessing what the patient and family needs. The family-focused approach not only emphasizes the experience, health, and safety of the patient but also the experience of the family member caring for the older adult. The study also involves families in education and provides families skills-building experiences that can help with caregiving stress, problem-solving, and communicating with the healthcare team. The approach will help the family member prepare for their loved one's transition home and provide coaching with the goal of reducing the mental, physical and financial burden of providing care at home. To spread the intervention across many states, the study team will be using telephone calls, video calls, and other technologies as families prefer.
Eligibility Criteria
Patient Inclusion Criteria: * 65 and older * English and Spanish speaking * Preadmission location: community dwelling * Distance from Hospital: Local and Distant (rural) included * Cognitive impairment, dementia allowed * Technology Literacy: Flexible from high to low * EPIC readmission risk score over 12 * Discharged home Patient Exclusion Criteria: * Admitted from skilled nursing facility * Discharged to skilled nursing facility * Left Against Medical Advice (AMA) * Planned readmission * Died during index admission * Caregiver unwilling to participate * Admitted to surgical services Caregiver Inclusion Criteria: * Adults 18 and older * English and Spanish speaking * Providing tangible support to patient * Distance from Hospital: Local and Distant (rural) included * Only Mild Cognitive Impairment allowed * Able to be trained in Video Visit Technology * Available to support post-discharge Caregiver Exclusion Criteria: • Has a greater than a mild cognitive impairment (\< 12 on MoCA)
Contact & Investigator
Thomas Houston, MD
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT07661355 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Care Transition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07661355 currently recruiting?
Yes, NCT07661355 is actively recruiting participants. Contact the research team at michiyah.kimber@advocatehealth.org for enrollment information.
Where is the NCT07661355 trial being conducted?
This trial is being conducted at Bermuda Run, United States, High Point, United States, North Wilkesboro, United States, Winston-Salem, United States.
Who is sponsoring the NCT07661355 clinical trial?
NCT07661355 is sponsored by Wake Forest University Health Sciences. The principal investigator is Thomas Houston, MD at Wake Forest University Health Sciences. The trial plans to enroll 2,560 participants.